Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: Etiology, incidence and predictors

Clinical Microbiology and Infection

Volumn 21, Issue 1, 2015, Pages 30-34

  Amit, S ^a   Mishali, H ^b   Kotlovsky, T ^b   Schwaber, M J ^b   Carmeli, Y ^b,c  

^a Infectious Diseases Unit   (Israel)

^b The National Centre for Antibiotic Resistance and Infection Control   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Bloodstream infections; Carbapenem resistant Klebsiella pneumoniae

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM CULTURE; BLOODSTREAM INFECTION; CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DIARRHEA; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; GRAM NEGATIVE BACTERIUM; HETEROZYGOTE DETECTION; HUMAN; INCIDENCE; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; PEPTOCLOSTRIDIUM DIFFICILE; PREDICTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; BACTEREMIA; DRUG EFFECTS; HETEROZYGOTE; ISRAEL; KLEBSIELLA INFECTIONS; MICROBIOLOGY; MIDDLE AGED; VERY ELDERLY;

ACINETOBACTER BAUMANNII; CLOSTRIDIUM DIFFICILE; ENTEROBACTERIACEAE; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA; PSEUDOMONAS AERUGINOSA;

AGED; AGED, 80 AND OVER; BACTEREMIA; CARBAPENEMS; CARRIER STATE; CASE-CONTROL STUDIES; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; ISRAEL; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84926318305     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2014.08.001     Document Type: Article

References (26)

1. Nordmann P., Cuzon G., Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009, 9:228-236.
2. Hirsch E.B., Tam V.H. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. JAntimicrob Chemother 2010, 65:1119-1125.
3. Schwaber M.J., Carmeli Y. Carbapenem-resistant Enterobacteriaceae: a potential threat. JAm Med Assoc 2008, 300:2911-2913.
4. Sievert D.M., Ricks P., Edwards J.R., Shcneider A., Patel J., Srinivasan A., et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 2013, 34:1-14.
5. European Antimicrobial Resistance Surveillance Network Antimicrobial resistance surveillance in Europe 2014, Available at:, [accessed 08.11.14]. http://www.ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-surveillance-europe-2011.pdf.
6. Glasner C., Albiger B., Buist G., Tambic-Andrasevic A., Canton R., Carmeli Y., et al. Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013. Euro Surveill 2013, 18:20525.
7. Najaraj S., Chandran S.P., Shamanna P., Macaden M. Carbapenem resistance among Escherichia coli and Klebsiella pneumonia in a tertiary care hospital in south India. Indian J Med Microbiol 2012, 30:93-95.
8. Gasink L.B., Edelstein P.H., Lautenbach E., Synnestvedt M., Fishman N.O. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing. Infect Control Hosp Epidemiol 2009, 30:1180-1185.
9. Hussein K., Sprecher H., Mashiach T., Oren I., Kassis I., Finkelstein R. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol 2009, 30:666-671.
10. Schwaber M.J., Klarfeld-Lidji S., Navon-Venezia S., Schwartz D., Leavitt A., Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008, 52:1028-1033.
11. Borer A., Saidel-Odes L., Riesenberg K., Eskira S., Peled N., Nativ R., et al. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol 2009, 30:972-976.
12. Patel G., Huprikar S., Factor S.H., Jenkins S.G., Calfee D.P. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008, 29:1099-1106.
13. Ben-David D., Kordevani R., Keller N., Tal I., Marzel A., Gal-Mor O., et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect 2012, 18:54-60.
14. European Centre for Disease Prevention and Control (ECDC) Risk assessment on the spread of carbapenemase-producing Enterobacteriaceae (CPE) through patient transfer between healthcare facilities, with special emphasis on cross-border transfer 2011, ECDC, Stockholm, Available at:, [accessed 8.11.14]. http://ecdc.europa.eu/en/publications/Publications/110913_Risk_assessment_resistant_CPE.pdf.
15. Centers for Disease Control and Prevention (CDC) Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 2009, 58:256-260.
16. Carmeli Y., Akova M., Cornaglia G., Daikos G.L., Garau J., Harbarth S., et al. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect 2010, 16:102-111.
17. Calfee D., Jenkins S.G. Use of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in intensive care unit patients. Infect Control Hosp Epidemiol 2008, 29:966-968.
18. Schwaber M.J., Carmeli Y. An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae. Clin Infect Dis 2014, 58:697-703.
19. Schechner V., Kotlovsky T., Kazma M., Mishali H., Schwartz D., Navon-Venezia S., et al. Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected?. Clin Microbiol Infect 2013, 19:451-456.
20. Borer A., Saidel-Odes L., Eskira S., Nativ R., Riesenberg K., Livshiz-Riven I., et al. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K.pneumonia. Am J Infect Control 2012, 40:421-425.
21. Pujol M., Peiia C., Pallares R., Ariza J., Ayats J., Domiguez M.A., et al. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 1996, 100:509-516.
22. Couet W., Gregoire N., Marchand S., Mimoz O. Colistin pharmacokinetics: the fog is lifting. Clin Microbiol Infect 2012, 18:30-39.
23. Meletis G., Tzampaz E., Sianou E., Tzavaras I., Sofianou D. Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae. JAntimicrob Chemother 2011, 66:946-947.
24. Paul M., Carmeli Y., Durante-Mangoni E., Mouton J.W., Tacconelli E., Theuretzbacher U., et al. Combination therapy for carbapenem-resistant Gram-negative bacteria. JAntimicrob Chemother 2014, 69(9):2305-2309.
25. Tumbarello M., Viale P., Viscoli C., Trecarichi E.M., Tumietto F., Marchese A., et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis 2012, 55:943-950.
26. Nutman A., Glick R., Temkin E., Hoshen M., Edgar R., Braun T., et al. Acase-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteremia. Clin Microbiol Infect 2014, [Epub ahead of print].